Johnson & Johnson JNJ Balance Sheet Statement
| TTM Q1 '26 | TTM Q4 '25 | TTM Q3 '25 | TTM Q2 '25 | TTM Q1 '25 | ||
|---|---|---|---|---|---|---|
| $21.69B+10.0% | $19.71B+8.1% | $18.23B-1.9% | $18.58B-51.7% | $38.47B+59.6% | ||
| $363M-7.6% | $393M+18.7% | $331M+9.2% | $303M-1.3% | $307M-26.4% | ||
| $17.72B+3.2% | $17.18B-2.5% | $17.61B-1.3% | $17.85B+11.4% | $16.02B+7.9% | ||
| $14.58B+2.8% | $14.19B+0.3% | $14.15B+5.5% | $13.41B+5.9% | $12.66B+1.7% | ||
| $4.82B+16.0% | $4.15B-3.2% | $4.29B-1.6% | $4.36B+6.6% | $4.09B+0.1% | ||
| $59.17B+6.4% | $55.62B+1.9% | $54.61B+0.2% | $54.5B-23.8% | $71.55B+28.0% | ||
| $23.27B+0.4% | $23.17B+3.7% | $22.34B+1.8% | $21.95B+5.2% | $20.87B+1.7% | ||
| $31.43B+0.7% | $31.2B+0.5% | $31.04B+1.7% | $30.52B+5.2% | $29.01B+2.7% | ||
| $48.56B-0.4% | $48.77B+1.5% | $48.05B-0.1% | $48.12B+8.2% | $44.47B+0.6% | ||
| $200.89B+0.8% | $199.21B+3.3% | $192.82B-0.3% | $193.39B-0.1% | $193.67B+7.5% | ||
| $10.46B-12.8% | $11.99B+24.6% | $9.63B+1.7% | $9.46B-0.8% | $9.55B-7.4% | ||
| $6.76B-2.8% | $6.96B+0.4% | $6.93B-1.3% | $7.02B-0.4% | $7.05B-2.9% | ||
| $17.46B+106% | $8.5B+33.0% | $6.39B-44.6% | $11.53B-17.1% | $13.9B+132% | ||
| $17.46B+106% | $8.5B+33.0% | $6.39B-44.6% | $11.53B-17.1% | $13.9B+132% | ||
| $57.72B+6.6% | $54.13B+6.4% | $50.87B-6.1% | $54.18B-4.8% | $56.9B+13.1% | ||
| $37.53B-4.8% | $39.44B+0.1% | $39.41B+0.4% | $39.24B+2.3% | $38.36B+25.1% | ||
| $10.21B+3.4% | $9.87B-0.6% | $9.93B-3.3% | $10.26B-1.6% | $10.44B-40.5% | ||
| $119.71B+1.7% | $117.67B+3.6% | $113.54B-1.2% | $114.92B-0.6% | $115.56B+6.4% | ||
| $169.16B+0.1% | $168.98B+1.0% | $167.28B+1.2% | $165.37B+1.7% | $162.64B+4.4% | ||
| -$14.83B+0.7% | -$14.93B+2.0% | -$15.24B-6.5% | -$14.31B-21.8% | -$11.74B0.0% | ||
| $76.26B+0.8% | $75.62B-0.3% | $75.89B+0.2% | $75.71B-0.3% | $75.91B+0.3% | ||
| $81.19B-0.4% | $81.54B+2.9% | $79.28B+1.0% | $78.47B+0.5% | $78.11B+9.3% | ||
| $200.89B+0.8% | $199.21B+3.3% | $192.82B-0.3% | $193.39B-0.1% | $193.67B+7.5% | ||
| $363M-7.6% | $393M+18.7% | $331M+9.2% | $303M-1.3% | $307M-26.4% | ||
| $6.73B-2.1% | $6.87B+3.1% | $6.67B-2.0% | $6.8B-19.9% | $8.49B-18.8% | ||
| $49.06B-2.7% | $50.4B+3.4% | $48.74B-2.2% | $49.84B+35.6% | $36.76B-2.3% | ||
| $14.11B-1.8% | $14.37B+15.7% | $12.42B+1.9% | $12.19B+5.7% | $11.53B+1.1% | ||
| $54.7B+0.6% | $54.36B+1.9% | $53.38B+1.7% | $52.47B+5.2% | $49.88B+2.3% | ||
| $14.11B-1.8% | $14.37B+15.7% | $12.42B+1.9% | $12.19B+5.7% | $11.53B+1.1% | ||
| $2.91B-35.8% | $4.53B+14.1% | $3.97B+20.4% | $3.3B+29.3% | $2.55B-38.2% | ||
| $7.4B-13.9% | $8.59B+13.1% | $7.6B+2.7% | $7.4B-6.4% | $7.91B-7.4% | ||
| $1.09B-21.7% | $1.39B-28.0% | $1.93B+15.8% | $1.67B-60.5% | $4.22B+11.8% | ||
| $7.4B-13.9% | $8.59B+13.1% | $7.6B+2.7% | $7.4B-6.4% | $7.91B-7.4% | ||
| $18.4B-3.8% | $19.12B-10.5% | $21.36B+2.6% | $20.82B+10.9% | $18.78B+6.8% | ||
| $2.91B-35.8% | $4.53B+14.1% | $3.97B+20.4% | $3.3B+29.3% | $2.55B-38.2% | ||
| $3.12B0.0% | $3.12B0.0% | $3.12B0.0% | $3.12B0.0% | $3.12B0.0% | ||
| $54.7B+0.6% | $54.36B+1.9% | $53.38B+1.7% | $52.47B+5.2% | $49.88B+2.3% | ||
| $486M0.0% | $486M+16.3% | $418M0.0% | $418M+5.8% | $395M+1.3% | ||
| $7.01B+3.2% | $6.79B+13.4% | $5.99B+57.6% | $3.8B+56.5% | $2.43B-0.8% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- What are Johnson & Johnson's total assets?
- Johnson & Johnson (JNJ) holds $200.89B in total assets, up 3.7% year over year.
- How much debt does Johnson & Johnson have?
- Johnson & Johnson carries $55.0B in total debt against $81.2B of shareholders' equity, a debt-to-equity ratio of 0.68.
- How much cash does Johnson & Johnson have?
- Johnson & Johnson holds $21.7B in cash and equivalents.
- Can Johnson & Johnson cover its short-term obligations?
- Its current ratio is 1.03 — current assets exceed current liabilities.
- Where does Johnson & Johnson's balance sheet data come from?
- Every line is extracted from Johnson & Johnson's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
